Use Able AI chat for product recommendations

VSIG4 Polyclonal antibody

VSIG4 Polyclonal Antibody for WB, ELISA

Cat No. 27829-1-AP

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, ELISA

CRIg, Protein Z39Ig, UNQ317/PRO362, V-set and immunoglobulin domain-containing protein 4, Z39IG

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inTT cells, U-251 cells, U-87 MG cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:4000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

27829-1-AP targets VSIG4 in WB, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag27214

Product name: Recombinant human VSIG4 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 305-399 aa of BC010525

Sequence: MLCRKTSQQEHVYEAARAHAREANDSGETMRVAIFASGCSSDEPTSQNLGNNYSDEPCIGQEYQIIAQINGNYARLLDTVPLDYEFLATEGKSVC

Predict reactive species
Full Name V-set and immunoglobulin domain containing 4
Calculated Molecular Weight 399 aa, 44 kDa
Observed Molecular Weight44 kDa
GenBank Accession NumberBC010525
Gene Symbol VSIG4
Gene ID (NCBI) 11326
RRIDAB_3742260
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9Y279
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

V-set and immunoglobulin domain-containing 4 (VSIG4) is a complement receptor of the immunoglobulin superfamily (CRIg) that is specifically expressed in resting tissue-resident macrophages . Notably, CRIg is expressed in monocyte-derived macrophages but not in human and mouse monocytes. VSIG4 can suppress T cell proliferation and promote Foxp3+ regulatory T cell (Tregs) differentiation by binding an unidentified receptor on T cells . VSIG4 has been implicated in a variety of diseases, particularly those involving immune dysregulation and inflammation, such as non-alcoholic steatohepatitis, rheumatoid arthritis, and obesity-related metabolic disorders . Recently, VSIG4+ tumor-associated macrophages (TAMs) have been identified as a specific subset that infiltrates aggressive cancers, including anaplastic thyroid cancer (ATC). (PMID: 37153746,PMID: 39920772)

Protocols

Product Specific Protocols
WB protocol for VSIG4 antibody 27829-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...
||
New chat

Able

正在加载,请稍候...